£109.04

Springer Rare Lymphomas (Hematologic Malignancies)

Price data last checked 172 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£109 today · usual range £0–£0 · best ever £34

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 559 days • 559 data points (No recent data available)

Historical
Generating forecast...
£119.99 £25.84 £46.38 £66.92 £87.47 £108.01 £128.55 09 June 2024 26 October 2024 15 March 2025 01 August 2025 19 December 2025

Price Distribution

Price distribution over 559 days • 10 price levels

Days at Price
Current Price
7 days 41 days 11 days 12 days 6 days 23 days 27 days 427 days 1 day · current 4 days 0 107 214 320 427 £34 £46 £48 £76 £91 £92 £94 £100 £109 £120 Days at Price

Price Analysis

Most common price: £100 (427 days, 76.4%)

Price range: £34 - £120

Price levels: 10 different prices over 559 days

Description

After a decade of tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma, optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors. Even more importantly, molecular targeted approaches have been shown to be effective in the treatment of distinct lymphoma subtypes. Against this background, clinical management of especially the rare lymphomas remains a challenge for the general oncologist. This book provides a comprehensive overview of current treatment strategies in these rare lymphoma subtypes. Experts in the field from around the world describe histomorphology in a clinically relevant manner, consider the role of risk factors in detail, and discuss the spectrum of therapeutic approaches. Special emphasis is placed on the translation of molecular science into clinical care, and a disease-specific algorithm is proposed for each entity.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
23 August 2016
Listed Since
20 July 2016

Barcode

No barcode data available

Similar Products You Might Like

Aggressive Lymphomas (Hematologic Malignancies)
98% match

Aggressive Lymphomas (Hematologic Malignancies)

Springer

£88.97 08 Mar 2026
Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology
98% match

Humana Lymphoma: Methods and Protocols - Methods in Molecular Biology

Humana

£101.00 18 Apr 2026
Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)
98% match

Lymphoma: Diagnosis and Treatment: 43 (Current Clinical Oncology, 43)

Humana

£141.36 01 Mar 2026
Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)
98% match

Advances in Lymphoma Research: 85 (Cancer Treatment and Research, 85)

Springer

£152.38 19 Dec 2025
Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)
98% match

Non-Hodgkin Lymphoma: Pathology, Imaging, and Current Therapy: 165 (Cancer Treatment and Research, 165)

Springer

£69.58 07 Mar 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
97% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£122.35 09 Mar 2026
Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research, 66)
97% match

Malignant lymphomas, including Hodgkin’s disease: Diagnosis, management, and special problems: 66 (Cancer Treatment and Research, 66)

Springer

£113.11 07 Jan 2026
Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)
97% match

Hodgkin Lymphoma: A Comprehensive Overview (Hematologic Malignancies)

Springer

£88.34 09 Mar 2026
Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)
97% match

Histopathology of Non-Hodgkin’s Lymphomas: (Based on the Updated Kiel Classification)

Springer

£77.82 11 Mar 2026
Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)
97% match

Lymphoma: Methods and Protocols: 1956 (Methods in Molecular Biology, 1956)

Humana

£117.00 28 Feb 2026
Skin Lymphoma: The Illustrated Guide
97% match

Skin Lymphoma: The Illustrated Guide

Wiley-Blackwell

£100.68 23 Jan 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
97% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£244.99 14 Jan 2026
Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)
97% match

Diagnosis and Therapy of Malignant Lymphoma: 46 (Recent Results in Cancer Research, 46)

Springer

£77.39 11 Mar 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
97% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£398.50 13 Jan 2026
Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)
97% match

Malignant Lymphomas and Hodgkin’s Disease: Experimental and Therapeutic Advances: Proceedings of the Second International Conference on Malignant ... – 16, 1984: 32 (Developments in Oncology, 32)

Springer

£291.99 11 Jan 2026
The WHO Classification of Tumours Haematolymphoid Tumours (Volume 11) 5th edition
96% match

The WHO Classification of Tumours Haematolymphoid Tumours (Volume 11) 5th edition

World Health Organization

£142.39 29 Jan 2026
Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)
96% match

Blut und Blutkrankheiten: Fünfte Völlig Neu Bearbeitete und Erweiterte Auflage: 2 / 7 (Handbuch der inneren Medizin, 2 / 7)

Springer

£57.70 19 Apr 2026
Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)
96% match

Resistance of Targeted Therapies Excluding Antibodies for Lymphomas: 17 (Resistance to Targeted Anti-Cancer Therapeutics, 17)

Springer

£78.10 01 Mar 2026
Neoplastic Hematopathology, An Issue of Hematology/Oncology Clinics of North America (Volume 23-4) (The Clinics: Internal Medicine, Volume 23-4)
96% match

Neoplastic Hematopathology, An Issue of Hematology/Oncology Clinics of North America (Volume 23-4) (The Clinics: Internal Medicine, Volume 23-4)

Saunders

£49.44 07 Mar 2026
Hematopathology of the Skin: Clinical & Pathological Approach
96% match

Hematopathology of the Skin: Clinical & Pathological Approach

Lippincott Williams & Wilkins

£210.19 26 Jan 2026
The International Consensus Classification of Myeloid and Lymphoid Neoplasms
96% match

The International Consensus Classification of Myeloid and Lymphoid Neoplasms

Lippincott Williams & Wilkins

£114.99 22 Feb 2026
The Lymphoid Neoplasms 3ed
96% match

The Lymphoid Neoplasms 3ed

CRC Press

£230.83 23 Feb 2026
Lymphoproliferative Diseases of the Skin
96% match

Lymphoproliferative Diseases of the Skin

Springer

£88.10 22 Feb 2026
PET/CT in Lymphomas: A Case-Based Atlas
96% match

PET/CT in Lymphomas: A Case-Based Atlas

Springer

£85.16 09 Mar 2026